Longevity Foundation
91
синергия
3
12,000
intermediate
May 17, 2026
Обзор
The Longevity Foundation stack addresses three fundamental pillars of biological aging: telomere attrition, extracellular matrix degradation, and immune senescence. Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It activates telomerase — the enzyme that rebuilds telomere caps on chromosomes — in somatic cells. In Khavinson''s clinical studies, Epithalon administration to elderly patients was associated with reduced mortality, improved immune markers, and normalization of melatonin production from the pineal gland. It is administered in 10-day cycles, typically twice per year. GHK-Cu is a naturally occurring copper-binding tripeptide that functions as a master regulator of tissue remodeling. Beyond its surface-level skin benefits, GHK-Cu modulates the expression of over 4,000 genes — many involved in DNA repair, antioxidant production (SOD, glutathione), stem cell proliferation, and suppression of pro-inflammatory cytokines. Its concentration in human plasma drops from 200 ng/mL at age 20 to 80 ng/mL by age 60, correlating with visible aging and reduced regenerative capacity. Thymosin Alpha-1 addresses immunosenescence — the progressive decline of immune function with age that increases susceptibility to infections, cancer, and autoimmune conditions. By promoting T-cell maturation, dendritic cell activation, and natural killer cell function, Ta1 helps restore immune surveillance to more youthful levels. The three-peptide combination creates a comprehensive anti-aging protocol: Epithalon maintains chromosomal integrity, GHK-Cu restores tissue remodeling capacity and gene expression patterns, and Thymosin Alpha-1 rejuvenates immune competence. This represents a systems-biology approach to aging rather than targeting any single pathway.
Протокол дозирования
10,000 mcg
на дозу
500 mcg
на дозу
1,500 mcg
на дозу
Цели и доказательства
Предупреждения
- Epithalon and GHK-Cu were removed from the FDA Category 2 list (April 2026) but remain pending PCAC review — not legal to compound yet. Thymosin Alpha-1 remains FDA Category 2 (restricted) in the US (approved abroad as Zadaxin). Epithalon cycles: 10 days on, 6 months off.
Comments
Sign in to join the discussion
Уведомление: Этот стак представлен сообществом и предназначен для исследовательских целей только. Peptide Contacts не проверяет безопасность или эффективность представленных стаков. Всегда проконсультируйтесь с квалифицированным медицинским специалистом перед использованием любого протокола пептидов.